ホーム › 膀胱癌 › ノースカロライナ

ノースカロライナにおける膀胱癌の臨床試験

ノースカロライナ内の拠点で、膀胱癌に関する26件の研究が参加者を募集しています。

ノースカロライナ内の都市

公式研究テキスト（英語）

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

AdventHealth Infusion Center Asheville, Asheville
Southeastern Medical Oncology Center-Clinton, Clinton
AdventHealth Infusion Center Haywood, Clyde
他6件

被験者募集中観察研究健康なボランティア歓迎

40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

UNC Lineberger Comprehensive Cancer Center, Chapel Hill

被験者募集中第2相

18歳以上 · 全性別 · 2026/10/02更新 · NCT06770582

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Margaret R Pardee Memorial Hospital, Hendersonville

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/30更新 · NCT03866382

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Duke Cancer Center Cary, Cary
Duke University Medical Center (location of scans), Durham
Duke University Medical Center - Duke University Hospital (location of scans), Durham
他5件

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/28更新 · NCT07421700

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

Biorepository and Precision Pathology Center (BRPC), Durham
Duke Cancer Institute, Durham
Substrate Services Core Research Support (SSCRS), Durham

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/28更新 · NCT07206225

DESTINY-PANTUMOUR04

Research Site, Durham
Research Site, Wilson

被験者募集中観察研究

18歳〜130歳 · 全性別 · 2026/09/25更新 · NCT07124000

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

WakeMed Raleigh Campus ( Site 0811), Raleigh

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/25更新 · NCT07419295

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Levine Cancer Institute, Charlotte
Oncology Specialists of Charlotte, Charlotte
Wake Forest Baptist Health, Winston-Salem

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/22更新 · NCT07218380

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Carolina Biooncology Institute, Huntersville

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/18更新 · NCT05267626

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

Duke University Medical Center - Duke Cancer Center, Durham

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/15更新 · NCT07217171

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

UNC- Chapel Hill, Chapel Hill

被験者募集中観察研究

18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

University of North Carolina, Chapel Hill
Atrium Health/Levine Center, Charlotte
Associated Urologist of North Carolina (Solaris), Raleigh

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/03更新 · NCT06567743

The Vanguard Study: Testing a New Way to Screen for Cancer

UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Durham VA Medical Center, Durham

被験者募集中健康なボランティア歓迎

45歳〜75歳 · 全性別 · 2026/09/02更新 · NCT06995898

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

University of North Carolina (UNC) - Chapel Hill, Chapel Hill

被験者募集中第1相

18歳以上 · 全性別 · 2026/08/20更新 · NCT05614739

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Research Site, Chapel Hill

被験者募集中第2/3相

18歳以上 · 全性別 · 2026/08/20更新 · NCT07129993

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Duke University Medical Center, Durham

被験者募集中第3相

18歳以上 · 全性別 · 2026/08/18更新 · NCT07097142

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

UNC Chapel Hill Hospital, Chapel Hill
Duke Health - Duke Cancer Center, Durham
Associated Urologists of North Carolina, Raleigh

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/08/07更新 · NCT04752722

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2

University of North Carolina, Chapel Hill

被験者募集中観察研究

18歳以上 · 全性別 · 2026/07/31更新 · NCT07225127

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Atrium Health Wake Forest Baptist - Comprehensive Cancer Center, Winston-Salem

被験者募集中第2相

8歳以上 · 全性別 · 2026/07/27更新 · NCT05503797

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill
UNC Lineberger Comprehensive Cancer Center / University of North Carolina, Chapel Hill
Carolinas Medical Center (biopsy only), Charlotte
他10件

被験者募集中第2相

18歳以上 · 全性別 · 2026/07/22更新 · NCT04879329